Drug Delivery with Targeted Nanoparticles
560,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
  • Gebundenes Buch

This book discusses the production, characterization, regulation, and currently marketed targeted nanoparticle systems in a broad framework.

Produktbeschreibung
This book discusses the production, characterization, regulation, and currently marketed targeted nanoparticle systems in a broad framework.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Y¿lmaz Çapan is Professor and Head of the Pharmaceutical Technology Department, Faculty of Pharmacy, Hacettepe University, Turkey. He obtained his bachelor¿s degree in pharmacy from Hacettepe University in 1972 and PhD with honors from the University of Lille, Faculty of Pharmacy, France, in 1978. He has authored more than 80 publications in prestigious, refereed pharmaceutical science journals, with a current citation number of more than 2000, and 3 books. Prof. Çapan is a member of the American Association of Pharmaceutical Scientists, the Association of Pharmaceutical Sciences of Ankara, the Turkish Pharmacists¿ Association, and the Pharmacist¿s Chamber of Ankara. His research interests include tabletting sustainedrelease oral solid dosage forms, bioadhesion, protein delivery from biodegradable microspheres, and brain drug targeting. Adem Sahin is Assistant Professor at the Faculty of Pharmacy, Selçuk University, Turkey. He obtained his bachelor¿s degree in pharmacy from Erciyes University, Turkey, in 2011 and PhD with honors from the Department of Pharmaceutical Technology, Hacettepe University, in 2017. He has been working in the pharmaceutical industry as a formulation specialist and a clinical trials executive and his research interests include brain drug delivery, cancer nanomedicine, and nanotechnology in drug delivery. Hayrettin Tonbul is Assistant Professor at the Faculty of Pharmacy, ¿nönü University, Turkey. He obtained his bachelor¿s degree in pharmacy from Near East University, Turkey, in 2015 and PhD with honors from the Department of Pharmaceutical Technology, Hacettepe University, in 2019. His research interests include controlled and targeted drug delivery, cancer nanomedicine, and nanotechnology in drug delivery.